Allergan and Gedeon Richter have secured US Food and Drug Administration (FDA) approval for the use of Vraylar (cariprazine) to treat bipolar I disorder.
Date:2019-06-03 Views:503
Allergan and Gedeon Richter have secured US Food and Drug Administration (FDA) approval for the use of Vraylar (cariprazine) to treat bipolar I disorder.
